Related Articles
Brachyury: A sensitive marker, but not a prognostic factor, for skull base chordomas
Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression Corrigendum in /10.3892/ijmm.2019.4119
Familial chordoma: A case report and review of the literature
WRN Cys1367Arg polymorphism is not associated with skull base chordoma
Partial response to imatinib treatment in a patient with unresectable gastrointestinal stromal tumor: A case report and mini literature review